Kingdon Capital Management’s Lipocine LPCN Stock Holding History

Kingdon Capital Management’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,461	Closed	-$597K	–	119
2016 Q1	$597K	Sell	3,461 -10,882	-76%	-$1.86M	0.03%	104
2015 Q4	$3.15M	Sell	14,343 -3,010	-17%	-$631K	0.15%	93
2015 Q3	$3.49M	Sell	17,353 -294	-2%	-$68K	0.17%	96
2015 Q2	$2.57M	Buy	+17,647	New	+$2.19M	0.1%	113

Other funds holding LPCN

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Kingdon Capital Management's LPCN Position: Q2 2016 in Review

Kingdon Capital Management sold out of Lipocine (LPCN) in Q2 2016, closing a stake of 3,461 shares — an estimated $597K sold.

Kingdon Capital Management first reported a position in LPCN in Q2 2015 and held it in 4 quarters. The position peaked at $3.49M in Q3 2015. 54 funds tracked by Wall St. Rank hold LPCN as of Q2 2016.

Kingdon Capital Management reported no remaining Lipocine position as of Q2 2016 after selling out during the quarter.
Kingdon Capital Management sold 3,461 Lipocine shares in Q2 2016, an estimated $597K.
Kingdon Capital Management first reported a position in Lipocine in Q2 2015 and held it in 4 quarters.
Kingdon Capital Management's Lipocine position peaked at $3.49M in Q3 2015.
54 funds tracked by Wall St. Rank held Lipocine as of Q2 2016.

Based on Kingdon Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.